Dongcheng Pharmaceutical's equity distribution plan for the first three quarters: 0.5 yuan will be paid a cash dividend for every 10 shares. Dongcheng Pharmaceutical (002675) announced on the evening of December 12 that the company's equity distribution plan for the first three quarters of 2024 is: based on the total share capital of 825 million shares on September 30, 2024, all shareholders will be paid a cash dividend of 0.5 yuan (including tax) for every 10 shares, totaling 41,229,800 yuan.Verification of insider trading between Guotai Junan and Haitong Securities: 11 insiders involved in buying and selling A-shares, including executives and their families. Guotai Junan and Haitong Securities both announced that insider information related to this transaction bought and sold A-shares of Guotai Junan and Haitong Securities. The situation was verified, involving 11 related natural persons buying and selling A-shares of Guotai Junan and Haitong Securities. Including Han Zhida, vice president of Guotai Junan, Zhao Hong, chief auditor of Guotai Junan, Xiong Xiaohua, mother of Shen Yun, supervisor of Guotai Junan, Huang Guan Tu, father of Huang Wenxin, employee of Guotai Junan, and Zhou Yang, spouse of Lv Na, an overseas legal consultant of Haitong Securities and a consultant lawyer of Gao Weishen Law Firm. According to relevant documents, based on the verification scope of insider information of this transaction and the self-inspection of relevant institutions and personnel, and on the premise that the self-inspection report, relevant explanations and commitments and interview confirmation information issued by the insider information are true, accurate and complete, the buying and selling of A shares of Guotai Junan and/or Haitong Securities by the above-mentioned relevant institutions and personnel during the self-inspection period does not constitute insider trading, and their buying and selling of shares will not constitute a substantial legal obstacle to this transaction.Morgan Stanley upgraded Dahua's rating to parity, with a target price of RMB in 19 yuan. Andy Meng, an analyst at Morgan Stanley, had a low rating. The target price is 19 yuan RMB, which is up by 12%.
According to informed sources, Stada Arzneimittel AG, a pharmaceutical company focusing on consumer health care, sounded out investors' interest before the German IPO. The company may raise about 1.5 billion euros ($1.6 billion) through an IPO.Brazil's Vale said it had reached an agreement with the US Department of Energy to provide financing of $282.9 million for the Louisiana plant until 2031.The yield of 20/30-year US Treasury bonds rose by more than 5 basis points on the release date of US CPI inflation data. Investors also paid attention to oil prices and Yellen's new debt supply. At the end of new york on Wednesday (December 11), the yield of US 10-year benchmark government bonds rose by 3.89 basis points to 4.2652%. After the release of US CPI inflation data at 21:30 Beijing time, it plunged significantly and refreshed at 22:41 (the beginning of US stock market). Then it rebounded, and the results released at 02:00 showed that the auction of 10-year US bonds was strong, the bid multiple reached a new high since 2016, and the yield reached 4.2750% at 03:00. The yield of two-year US bonds rose by 1.02 basis points to 4.1532%, and reached 4.1741% at 21:17 (less than a quarter of an hour before the release of the US CPI data). After the data was released, it plunged, and reached 4.0969% at 22:41, and then gradually rebounded.
Morgan Stanley upgraded Hongyuan Green Energy Co., Ltd. to parity.Ferrous lithium phosphate has strong demand, so it is hard to hide the embarrassment of "meager profit" because the orders of enterprises are full. In December, the Ferrous lithium phosphate market continued to heat up, and most enterprises had full orders. However, contrary to the fiery market, it is still difficult for most enterprises to reverse the "meager profit" situation. "From the market situation, the growth in demand for new energy vehicles and energy storage markets has promoted the warming of the Ferrous lithium phosphate market. Most Ferrous lithium phosphate enterprises are affected by factors such as rising raw material prices, weak bargaining power of products and fierce competition in the industry, resulting in pressure on profits. " Researchers said that in the long run, with the technological progress and market expansion, the profitability of Ferrous lithium phosphate enterprises is expected to improve. (Securities Daily)Nevada Power Company applied to hold up to $2.1 billion in debt.
Strategy guide 12-14
Strategy guide
12-14